Anorexia nervosa and bulimia nervosa: are these diseases really antipodes?

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Anorexia nervosa and bulimia nervosa are the main forms of eating disorders that characterized by both obvious similarities and certain differences between each other. The commonality of the two disorders is determined by the predominant occurrence in adolescent and young women, deterioration of physical health, significant psychiatric comorbidity and high suicidal risk. Psychotherapy is the principal treatment for both anorexia nervosa and bulimia nervosa. At the same time, unlike anorexia nervosa, the pharmacological agents with proven clinical efficacy for the treatment of bulimia nervosa exist. Patients with bulimia nervosa are more motivated and adherent to treatment.

About the authors

Yury P. Sivolap

RUDN University

Author for correspondence.
Email: yura-sivolap@yandex.ru
ORCID iD: 0000-0002-4494-149X
SPIN-code: 3586-5225
Scopus Author ID: 6604012934

M.D., D. Sci. (Med.), Prof.

Russian Federation, Moscow

Anna A. Portnova

The Serbsky State Scientific Center for Social and Forensic Psychiatry

Email: aapserbsky@mail.ru
ORCID iD: 0000-0001-5938-0202
SPIN-code: 5899-0069
Scopus Author ID: 6602193535

M.D., D. Sci. (Med.)

Russian Federation, Moscow

References

  1. Black DW, Andreasen NC. Introductory textbook of psychiatry. Sixth Edition. Arlington: American Psychiatric Publishing; 2014. 760 p.
  2. Attia E, Walsh T. Anorexia nervosa. In.: MSD Manual Professional Version, 2022. https://www.msdmanuals.com/professional/psychiatric-disorders/eating-disorders/anorexia-nervosa (access date: 11.05.2023).
  3. Semple D, Smyth R. Oxford handbook of psychiatry. Third Edition. Oxford: Oxford University Press; 2013. 1057 p.
  4. Mereu A, Fantoni T, Caini S et al. Suicidality in adolescents with onset of anorexia nervosa. Eat Weight Disord. 2022;27(7):2447–2457. doi: 10.1007/s40519-022-01384-9.
  5. Tyrer P, Silk KR. Effective treatment in psychiatry. Cambridge: Cambridge University Press; 2011. 563 p.
  6. Lutter M. Emerging treatments in eating disorders. Neurotherapeutics. 2017;14(3):614–622. doi: 10.1007/s13311-017-0535-x.
  7. National Institute for Health and Clinical Excellence. Eating disorders: Core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. Clinical Guidance 9. www.nice.org.uk (access date: 11.05.2023).
  8. Couturier J, Isserlin L, Norris M et al. Canadian practice guidelines for the treatment of children and adolescents with eating disorders. J Eat Disord. 2020;8:4. doi: 10.1186/s40337-020-0277-8.
  9. Kaye WH, Bulik CM. Treatment of patients with anorexia nervosa in the US — A crisis in care. JAMA Psychiatry. 2021;78(6):591–592. doi: 10.1001/jamapsychiatry.2020.4796.
  10. Attia E, Walsh T. Anorexia nervosa. In.: MSD Manual Professional Version, 2022. https://www.msdmanuals.com/professional/psychiatric-disorders/eating-disorders/bulimia-nervosa (access date: 11.05.2023).
  11. Mandelli L, Arminio A, Atti A-R, De Ronchi D. Suicide attempts in eating disorder subtypes: A meta-analysis of the literature employing DSM-IV, DSM-5, or ICD-10 diagnostic criteria. Psychol Med. 2019;49(8):1237–1249. doi: 10.1017/S0033291718003549.
  12. Crow SJ, Swanson SA, Grange D et al. Suicidal behavior in adolescents and adults with bulimia nervosa. Compr Psychiatry. 2014;55(7):1534–1539. doi: 10.1016/j.comppsych.2014.05.021.
  13. Tith RM, Paradis G, Potter BJ et al. Association of bulimia nervosa with long-term risk of cardiovascular disease and mortality among women. JAMA Psychiatry. 2020;77(1):44–51. doi: 10.1001/jamapsychiatry.2019.2914.
  14. Palmer EP, Guay AT. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med. 1985;313(23):1457–1459. doi: 10.1056/NEJM198512053132306.
  15. Hagan KE, Walsh BT. State of the art: The therapeutic approaches to bulimia nervosa. Review Clin Ther. 2021;43(1):40–49. doi: 10.1016/j.clinthera.2020.10.012.
  16. McElroy SL, Guerdjikova AI, Mori N, Romo-Nava F. Progress in developing pharmacologic agents to treat bulimia nervosa. CNS Drugs. 2019;33(1):31–46. doi: 10.1007/s40263-018-0594-5.
  17. Lekgabe E, Pogos D, Sawyer SM et al. Borderline personality disorder traits in adolescents with anorexia nervosa. Brain Behav. 2021;11(12):e2443. doi: 10.1002/brb3.2443.
  18. Miller AE, Racine SE, Klonsky ED. Symptoms of anorexia nervosa and bulimia nervosa have differential relationships to borderline personality disorder symptoms. Eat Disord. 2021;29(2):161–174. doi: 10.1080/10640266.2019.1642034.
  19. Monteleone AM, Castellini G, Volpe U et al. Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry. 2018;80(Pt B):132–142. doi: 10.1016/j.pnpbp.2017.02.020.
  20. Stamu-Obrien C, Shivakumar S, Messas T, Kroumpouzos G. Through the looking glass: Skin signs that help diagnose eating disorders. Clin Dermatol. 2023;S0738-081X(23)00032-9. doi: 10.1016/j.clindermatol.2023.03.005.

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies